Plasma BMP9 levels are normal in the majority of PAH patients81 and although circulating activin A is elevated in PAH patients, levels of the endogenous activin antagonist, follistatin, are also increased.120. The gene discussed is FST; the disease is pulmonary arterial hypertension.